FDA Approved: PLEGRIDY PEN — Supplemental Application (Biogen Inc.)

View source ↗

Summary

The FDA approved Biogen's supplemental application for Plegridy Pen, the autoinjector device for peginterferon beta-1a, for use in treating multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• PLEGRIDY PEN (Peginterferon beta-1a)

Snippet

SUPPL AP for PLEGRIDY PEN (PEGINTERFERON BETA-1A)